MyCartis, a Biocartis spin-out, is a commercial-stage biomarker discovery and diagnostic platform company. Together with strategic partners, the company develops and distributes the Evalution platform for immunoassay analysis. This platform offers user the possibility to work with multiple assay types and formats, to create multiplex assays and to run samples within the instrument, allowing full workflow integration.